These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Significantly increased concentration of soluble urokinase-type plasminogen activator receptor in the blood of patients with pelvic inflammatory disease. Yeh YH; Wang PH; Lin LY; Tee YT; Chou MC; Yang SF; Tsai HT Clin Chim Acta; 2013 Jan; 415():138-44. PubMed ID: 23117033 [TBL] [Abstract][Full Text] [Related]
6. [Can mannose-binding lectin and plasma level of soluble urokinase receptor be used in diagnosis and treatment monitorization of brucellosis patients?]. Karsen H; Cesur S; Karaağaç L; Binici I; Fidan Y; Oğüş E; Demiröz AP Mikrobiyol Bul; 2012 Jul; 46(3):519-21. PubMed ID: 22951667 [TBL] [Abstract][Full Text] [Related]
7. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Chafetz I; Kuhnreich I; Sammar M; Tal Y; Gibor Y; Meiri H; Cuckle H; Wolf M Am J Obstet Gynecol; 2007 Jul; 197(1):35.e1-7. PubMed ID: 17618748 [TBL] [Abstract][Full Text] [Related]
8. First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk. Khalil A; Cowans NJ; Spencer K; Goichman S; Meiri H; Harrington K Prenat Diagn; 2009 Aug; 29(8):781-9. PubMed ID: 19418482 [TBL] [Abstract][Full Text] [Related]
10. [Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester]. Ye YH; Liu L; Zhan Y; Peng W Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):433-5. PubMed ID: 17083803 [TBL] [Abstract][Full Text] [Related]
11. Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia. Laigaard J; Sørensen T; Placing S; Holck P; Fröhlich C; Wøjdemann KR; Sundberg K; Shalmi AC; Tabor A; Nørgaard-Pedersen B; Ottesen B; Christiansen M; Wewer UM Obstet Gynecol; 2005 Jul; 106(1):144-9. PubMed ID: 15994630 [TBL] [Abstract][Full Text] [Related]
12. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia. Spencer K; Cowans NJ; Nicolaides KH Ultrasound Obstet Gynecol; 2008 Oct; 32(5):622-6. PubMed ID: 18816493 [TBL] [Abstract][Full Text] [Related]
13. Early onset preeclampsia and second trimester serum markers. Lambert-Messerlian GM; Palomaki GE; Neveux LM; Chien E; Friedman A; Rosene-Montella K; Hayes M; Canick JA Prenat Diagn; 2009 Dec; 29(12):1109-17. PubMed ID: 19842088 [TBL] [Abstract][Full Text] [Related]
18. Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia. Powers RW; Roberts JM; Cooper KM; Gallaher MJ; Frank MP; Harger GF; Ness RB Am J Obstet Gynecol; 2005 Jul; 193(1):185-91. PubMed ID: 16021077 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of intact and cleaved forms of the urokinase plasminogen activator receptor in a retrospective study of 518 colorectal cancer patients. Lomholt AF; Christensen IJ; Høyer-Hansen G; Nielsen HJ Acta Oncol; 2010 Aug; 49(6):805-11. PubMed ID: 20524776 [TBL] [Abstract][Full Text] [Related]
20. Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality. Zimmermann HW; Reuken PA; Koch A; Bartneck M; Adams DH; Trautwein C; Stallmach A; Tacke F; Bruns T J Intern Med; 2013 Jul; 274(1):86-100. PubMed ID: 23432143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]